Document is current
Any future updates will be listed below
-
Authors
Vaz-Salgado, María Ángeles https://orcid.org/0000-0002-5913-9002
del Barco, Sonia https://orcid.org/0000-0002-4951-6871
Sepúlveda, Juan Manuel
Alonso, Miriam
Pineda, Estela
Balana, Carmen https://orcid.org/0000-0003-0771-0390
Martínez-García, María
Gironés, Regina
-
Funding
Funding for this research was provided by:
Pfizer (Not applicable)
- License Information
-
More Information
Article History
Received: 12 March 2025
Accepted: 12 November 2025
First Online: 4 December 2025
Competing interests
: The authors declare no competing interests. MAV declares to receive a grant and act as a speaker for Pfizer, participate in advisory boards for Novocure, act as a speaker, receive congress fees from Pharmamar, participate in advisory boards, and receive congress fees from Servier. MM-G declares to participate in advisory boards for Novocure, act as speaker for Novocure, and receive congress fees from Pfizer. EP declares to participate in advisory boards for Novocure and Servier, and receive congress fees from Pfizer. All other co-authors declare no conflicts of interest regarding this study.
